This traditional pathway involves an accumulation of activating mutations in oncogenes and deactivating mutations in tumor-suppressor genes, and appears to result in CRC resulting from MSS, non-CIMP, and absent BRAF or KRAS somatic mutations [101]. Here, KRAS is linked to colorectal carcinoma.